S. Sierakowski

6.3k total citations
12 papers, 86 citations indexed

About

S. Sierakowski is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Sierakowski has authored 12 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in S. Sierakowski's work include Systemic Lupus Erythematosus Research (5 papers), Systemic Sclerosis and Related Diseases (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). S. Sierakowski is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Systemic Sclerosis and Related Diseases (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). S. Sierakowski collaborates with scholars based in Poland, United States and Switzerland. S. Sierakowski's co-authors include Piotr Adrian Klimiuk, Anna Kuryliszyn-Moskal, James S. Goodwin, Bogdan Cylwik, J Skowroński, Justyna Chwiećko, Eugeniusz J. Kucharz, Robert W. Lightfoot, Piotr Leszczyński and Otylia Kowal‐Bielecka and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinica Chimica Acta and Clinical Rheumatology.

In The Last Decade

S. Sierakowski

11 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Sierakowski Poland 5 47 34 29 11 11 12 86
Ryochi Yoshida Japan 7 48 1.0× 37 1.1× 16 0.6× 11 1.0× 8 0.7× 11 99
Avram Goldberg United States 3 56 1.2× 42 1.2× 51 1.8× 10 0.9× 22 2.0× 4 105
V. Werth United States 6 57 1.2× 36 1.1× 30 1.0× 8 0.7× 14 1.3× 18 105
Elia Valls Pascual Spain 7 49 1.0× 15 0.4× 10 0.3× 13 1.2× 15 1.4× 32 164
Mariana Brandão Portugal 5 37 0.8× 28 0.8× 11 0.4× 14 1.3× 9 0.8× 19 105
Elise Descamps France 5 42 0.9× 12 0.4× 17 0.6× 8 0.7× 12 1.1× 11 87
Yusuke Sugimori Japan 7 30 0.6× 47 1.4× 20 0.7× 23 2.1× 4 0.4× 9 101
Hanna Graßhoff Germany 4 25 0.5× 76 2.2× 19 0.7× 22 2.0× 6 0.5× 6 129
Kiyohiro Tsutsui Japan 5 33 0.7× 9 0.3× 24 0.8× 18 1.6× 6 0.5× 9 89
William Schnitz United States 4 55 1.2× 26 0.8× 21 0.7× 5 0.5× 30 2.7× 4 77

Countries citing papers authored by S. Sierakowski

Since Specialization
Citations

This map shows the geographic impact of S. Sierakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sierakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sierakowski more than expected).

Fields of papers citing papers by S. Sierakowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Sierakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sierakowski. The network helps show where S. Sierakowski may publish in the future.

Co-authorship network of co-authors of S. Sierakowski

This figure shows the co-authorship network connecting the top 25 collaborators of S. Sierakowski. A scholar is included among the top collaborators of S. Sierakowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Sierakowski. S. Sierakowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chrostek, Lech, Ewa Gińdzieńska‐Sieśkiewicz, Ewa Gruszewska, et al.. (2019). Serum hyaluronic acid concentration in rheumatic diseases. Clinica Chimica Acta. 493. S95–S96.
2.
Majdan, Maria, Eugeniusz J. Kucharz, Sławomir Jeka, et al.. (2014). AB0494 Early Clinical Experiences with Belimumab in Polish Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 73. 970–970. 1 indexed citations
3.
Bielecki, M, Oliver Distler, L Chyczewski, et al.. (2012). SAT0024 Increased production of leukotrienes by peripheral blood mononuclear cells is associated with more severe disease and worse prognosis in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 71. 479–479. 2 indexed citations
4.
Chwiećko, Justyna, S. Sierakowski, Oliver Distler, et al.. (2008). Eicosanoid production in the peripheral blood mononuclear cells (PBMC) from patients with systemic sclerosis. Joint Bone Spine. 75(2). 246–247. 1 indexed citations
5.
Kuryliszyn-Moskal, Anna, et al.. (2008). Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Scandinavian Journal of Rheumatology. 38(1). 38–45. 33 indexed citations
6.
Klimiuk, Piotr Adrian, et al.. (2003). Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.. PubMed. 21(1). 63–9. 27 indexed citations
7.
Lemancewicz, Adam, et al.. (2002). Evaluation of interleukin concentrations in amniotic fluid in preterm and term parturition and in oligohydramnios.. PubMed. 7(5). 924–7. 2 indexed citations
8.
Klimiuk, Piotr Adrian & S. Sierakowski. (2001). [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].. PubMed. 11(66). 510–3. 2 indexed citations
9.
Sierakowski, S., et al.. (1989). Serum level of parathyroid hormone in certain rheumatic diseases.. PubMed. 26(4). 273–8. 1 indexed citations
10.
Kucharz, Eugeniusz J., S. Sierakowski, & James S. Goodwin. (1988). Decreased activity of interleukin-2 inhibitor in plasma of patients with systemic lupus erythematosus. Clinical Rheumatology. 7(1). 87–90. 5 indexed citations
11.
Sierakowski, S. & James S. Goodwin. (1988). Mechanism of action of glucocorticoid-induced immunoglobulin production: II. Requirement for fetal calf serum.. PubMed. 71(1). 198–201. 5 indexed citations
12.
Sierakowski, S., Eugeniusz J. Kucharz, Robert W. Lightfoot, & James S. Goodwin. (1987). Interleukin-1-production by monocytes from patients with systemic lupus erythematosus. Clinical Rheumatology. 6(3). 403–407. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryochi Yoshida Breakdown of academic impact, for papers by Avram Goldberg Breakdown of academic impact, for papers by V. Werth Breakdown of academic impact, for papers by Elia Valls Pascual Breakdown of academic impact, for papers by Mariana Brandão Breakdown of academic impact, for papers by Elise Descamps Breakdown of academic impact, for papers by Yusuke Sugimori Breakdown of academic impact, for papers by Hanna Graßhoff Breakdown of academic impact, for papers by Kiyohiro Tsutsui Breakdown of academic impact, for papers by William Schnitz
Rankless by CCL
2026